SDJ
3 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Adjunctive Cardiac Amyloidosis Status Indicator
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 870.2200
- Medical specialty
- Cardiovascular
- FDA definition
- The adjunctive cardiac amyloidosis status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting cardiac amyloidosis. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Us2.ca (K250151) | Eko.Ai Pte Ltd. D/B/A Us2.Ai | 2025-06-20 |
| InVision Precision Cardiac Amyloid (K243866) | InVision Medical Technology Corporation | 2025-05-21 |
| EchoGo Amyloidosis (1.0) (K240860) | Ultromics Limited | 2024-11-15 |
Track SDJ automatically
Every clearance here is in the API, with alerts when new ones post.